help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fan, W.
Right arrow Articles by Cone, R. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fan, W.
Right arrow Articles by Cone, R. D.
Endocrinology Vol. 141, No. 9 3072-3079
Copyright © 2000 by The Endocrine Society

ARTICLES

The Central Melanocortin System Can Directly Regulate Serum Insulin Levels1

Wei Fan, Daniela M. Dinulescu, Andrew A. Butler, Jeanie Zhou, Daniel L. Marks and Roger D. Cone

The Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201

Address all correspondence and requests for reprints to: Roger D. Cone, Ph.D., Vollum Institute, Oregon Health Sciences University, Portland, Oregon 97201. E-mail: cone{at}ohsu.edu

The central melanocortin system has been demonstrated to play a pivotal role in energy homeostasis. Genetic disruption of this system causes obesity in both humans and mice. Previous experiments have shown that centrally-administered melanocortin agonists inhibit food intake and stimulate oxygen consumption. Here we report that centrally-administered melanocortin agonists also inhibit basal insulin release, and alter glucose tolerance. Furthermore, increased plasma insulin levels occur in the young lean MC4-R knockout (MC4-RKO) mouse, and impaired insulin tolerance takes place before the onset of detectable hyperphagia or obesity. These data suggest that the central melanocortin system regulates not only energy intake and expenditure, but also processes related to energy partitioning, as indicated by effects on insulin release and peripheral insulin responsiveness. Previous studies emphasize the role of excess adipose mass in the development of tissue insulin resistance, leading to type II diabetes. The data presented here show that defects in the central control of glucose homeostasis may be an additional factor in some types of obesity-associated type II diabetes.




This article has been cited by other articles:


Home page
 EndocrinologyHome page
S. Park, S. M. Hong, S. R. Sung, and H. K. Jung
Long-Term Effects of Central Leptin and Resistin on Body Weight, Insulin Resistance, and {beta}-Cell Function and Mass by the Modulation of Hypothalamic Leptin and Insulin Signaling
Endocrinology, February 1, 2008; 149(2): 445 - 454.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. L. J. Ellacott, J. G. Murphy, D. L. Marks, and R. D. Cone
Obesity-Induced Inflammation in White Adipose Tissue Is Attenuated by Loss of Melanocortin-3 Receptor Signaling
Endocrinology, December 1, 2007; 148(12): 6186 - 6194.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
Y. Song and R. D. Cone
Creation of a genetic model of obesity in a teleost
FASEB J, July 1, 2007; 21(9): 2042 - 2049.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Lee, A. Kim, S. C. Chua Jr., S. Obici, and S. L. Wardlaw
Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E121 - E131.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J.-C. Peter, J. R. Nicholson, D. Heydet, A.-C. Lecourt, J. Hoebeke, and K. G. Hofbauer
Antibodies against the melanocortin-4 receptor act as inverse agonists in vitro and in vivo
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2151 - R2158.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
R. D. Cone
Studies on the Physiological Functions of the Melanocortin System
Endocr. Rev., December 1, 2006; 27(7): 736 - 749.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
I. S. Farooqi and S. O'Rahilly
Genetics of Obesity in Humans
Endocr. Rev., December 1, 2006; 27(7): 710 - 718.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
L. S. Tallam, A. A. da Silva, and J. E. Hall
Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin
Hypertension, July 1, 2006; 48(1): 58 - 64.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Watson, S. Hahm, T. M. Mizuno, J. Windsor, C. Montgomery, P. E. Scherer, C. V. Mobbs, and S. R. J. Salton
VGF Ablation Blocks the Development of Hyperinsulinemia and Hyperglycemia in Several Mouse Models of Obesity
Endocrinology, December 1, 2005; 146(12): 5151 - 5163.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. E. Levin, C. Magnan, S. Migrenne, S. C. Chua Jr., and A. A. Dunn-Meynell
F-DIO obesity-prone rat is insulin resistant before obesity onset
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R704 - R711.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. P. Coll, B. G. Challis, M. Lopez, S. Piper, G. S.H. Yeo, and S. O'Rahilly
Proopiomelanocortin-Deficient Mice Are Hypersensitive to the Adverse Metabolic Effects of Glucocorticoids
Diabetes, August 1, 2005; 54(8): 2269 - 2276.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. H. Lee, J. W. Bullen Jr., V. L. Stoyneva, and C. S. Mantzoros
Circulating resistin in lean, obese, and insulin-resistant mouse models: lack of association with insulinemia and glycemia
Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E625 - E632.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Santoro, E. M. del Giudice, G. Cirillo, P. Raimondo, I. Corsi, A. Amato, A. Grandone, and L. Perrone
An Insertional Polymorphism of the Proopiomelanocortin Gene Is Associated with Fasting Insulin Levels in Childhood Obesity
J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4846 - 4849.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
E. Savontaus, T. L. Breen, A. Kim, L. M. Yang, S. C. Chua Jr., and S. L. Wardlaw
Metabolic Effects of Transgenic Melanocyte-Stimulating Hormone Overexpression in Lean and Obese Mice
Endocrinology, August 1, 2004; 145(8): 3881 - 3891.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Khairallah, F. Labarthe, B. Bouchard, G. Danialou, B. J. Petrof, and C. Des Rosiers
Profiling substrate fluxes in the isolated working mouse heart using 13C-labeled substrates: focusing on the origin and fate of pyruvate and citrate carbons
Am J Physiol Heart Circ Physiol, April 1, 2004; 286(4): H1461 - H1470.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. J. Kuo, A. A. da Silva, L. S. Tallam, and J. E. Hall
Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation
Hypertension, February 1, 2004; 43(2): 370 - 375.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
I.S. Farooqi and S. O'Rahilly
Monogenic Human Obesity Syndromes
Recent Prog. Horm. Res., January 1, 2004; 59(1): 409 - 424.
[Abstract] [Full Text]

Home page
 DiabetesHome page
S. Bluher, M. Ziotopoulou, J. W. Bullen Jr, S. J. Moschos, L. Ungsunan, E. Kokkotou, E. Maratos-Flier, and C. S. Mantzoros
Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice
Diabetes, January 1, 2004; 53(1): 82 - 90.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. C. Albarado, J. McClaine, J. M. Stephens, R. L. Mynatt, J. Ye, A. W. Bannon, W. G. Richards, and A. A. Butler
Impaired Coordination of Nutrient Intake and Substrate Oxidation in Melanocortin-4 Receptor Knockout Mice
Endocrinology, January 1, 2004; 145(1): 243 - 252.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
U. Hochgeschwender, J. L. Costa, P. Reed, S. Bui, and M. B. Brennan
Altered Glucose Homeostasis in Proopiomelanocortin-Null Mouse Mutants Lacking Central and Peripheral Melanocortin
Endocrinology, December 1, 2003; 144(12): 5194 - 5202.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. M. Mizuno, K. A. Kelley, G. M. Pasinetti, J. L. Roberts, and C. V. Mobbs
Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice
Diabetes, November 1, 2003; 52(11): 2675 - 2683.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
L. K. HEISLER, M. A. COWLEY, T. KISHI, L. H. TECOTT, W. FAN, M. J. LOW, J. L. SMART, M. RUBINSTEIN, J. B. TATRO, J. M. ZIGMAN, et al.
Central Serotonin and Melanocortin Pathways Regulating Energy Homeostasis
Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 169 - 174.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
M. B. BRENNAN, J. L. COSTA, S. FORBES, P. REED, S. BUI, and U. HOCHGESCHWENDER
{alpha}-Melanocyte-Stimulating Hormone Is a Peripheral, Integrative Regulator of Glucose and Fat Metabolism
Ann. N.Y. Acad. Sci., June 1, 2003; 994(1): 282 - 287.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. Cornish, K. E. Callon, K. G. Mountjoy, U. Bava, J.-M. Lin, D. E. Myers, D. Naot, and I. R. Reid
alpha -Melanocyte-stimulating hormone is a novel regulator of bone
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1181 - E1190.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
I. S. Farooqi, J. M. Keogh, G. S.H. Yeo, E. J. Lank, T. Cheetham, and S. O'Rahilly
Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor Gene
N. Engl. J. Med., March 20, 2003; 348(12): 1085 - 1095.
[Abstract] [Full Text] [PDF]

Home page
 HypertensionHome page
J. J. Kuo, A. A. Silva, and J. E. Hall
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Hypertension, March 1, 2003; 41(3): 768 - 774.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
L. K. Heisler, M. A. Cowley, L. H. Tecott, W. Fan, M. J. Low, J. L. Smart, M. Rubinstein, J. B. Tatro, J. N. Marcus, H. Holstege, et al.
Activation of Central Melanocortin Pathways by Fenfluramine
Science, July 26, 2002; 297(5581): 609 - 611.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. D. Pierroz, M. Ziotopoulou, L. Ungsunan, S. Moschos, J. S. Flier, and C. S. Mantzoros
Effects of Acute and Chronic Administration of the Melanocortin Agonist MTII in Mice With Diet-Induced Obesity
Diabetes, May 1, 2002; 51(5): 1337 - 1345.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society